Bettina A. Hamelin

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

Peter J. Kahrilas, Gary W. Falk, David A. Johnson et al. · Alimentary Pharmacology & Therapeutics · 2000 · 356 citations

Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4<i>H</i>-chromenes, a novel series of anticancer agents

Henriette Gourdeau, Lorraine Leblond, Bettina A. Hamelin et al. · Molecular Cancer Therapeutics · 2004 · 285 citations

Treating the symptoms of gastro‐oesophageal reflux disease: a double‐blind comparison of omeprazole and cisapride

J. P. Galmiche, Philippe Barthélémy, Bettina A. Hamelin · Alimentary Pharmacology & Therapeutics · 1997 · 213 citations · Full text

Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.

Étienne Lessard, Marie‐Andrée Yessine, Bettina A. Hamelin et al. · PubMed · 1999 · 177 citations

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +22

Block of the Rapid Component of the Delayed Rectifier Potassium Current by the Prokinetic Agent Cisapride Underlies Drug-Related Lengthening of the QT Interval

Benoît Drolet, Majed Khalifa, Pascal Daleau et al. · Circulation · 1998 · 161 citations